AskVantage

Flagship Pioneering

Flagship Pioneering is a venture capital investor based in Cambridge, United States, founded in 1999. In short: American venture capital company. Open records document 11 investments.

Part of the 311 Institute Global Investors Directory (311institute.com). Last updated .

Venture capitalType
Cambridge, United StatesHeadquarters
1999Founded
11Documented investments
0In our Startups Directory
0Unicorn stakes
See it on the interactive mapVisit website

Other documented investments

Anellovirus compositions and methods of use, Anellovirus compositions and methods of use, Compositions and methods for cell delivery, Compositions and related methods for agriculture, Compositions comprising circular polyribonucleotides and uses thereof, Compositions comprising circular polyribonucleotides and uses thereof, Methods and compositions for modulating gene expression, Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators, Methods and compositions for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activators, Methods of modulating immune activity, Postbiotic compositions and related methods for agriculture.

Other investors in United States

Related

Questions and answers

What kind of investor is Flagship Pioneering?

Flagship Pioneering is a venture capital investor based in Cambridge, United States.

Where is Flagship Pioneering based?

Flagship Pioneering is headquartered in Cambridge, United States.

What has Flagship Pioneering invested in?

Documented investments include Anellovirus compositions and methods of use, Anellovirus compositions and methods of use, Compositions and methods for cell delivery, Compositions and related methods for agriculture, Compositions comprising circular polyribonucleotides and uses thereof, Compositions comprising circular polyribonucleotides and uses thereof, Methods and compositions for modulating gene expression, Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators, Methods and compositions for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activators, Methods of modulating immune activity.

Source record: Wikidata.

© 311 Institute 2026. Facts from Wikidata (CC0) and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.